Dr. Sarah Altman is participating in a clinical trial to evaluate the efficacy of a novel neurokinin-3 receptor antagonist compared to a placebo in improving menstrual regularity, hirsutism, and other symptoms in women between 18-45 years of age with oligo-amenorrhea due to PCOS.
Please contact Dr. Sarah Altman if you are interested:
Aventiv Research 614-501-6164
99 N Brice Rd Suite 260 Columbus, OH 43213
sartman@aventivresearch.com